144 related articles for article (PubMed ID: 29368368)
1. FOXK2 suppresses the malignant phenotype and induces apoptosis through inhibition of EGFR in clear-cell renal cell carcinoma.
Zhang F; Ma X; Li H; Zhang Y; Li X; Chen L; Guo G; Gao Y; Gu L; Xie Y; Duan J; Zhang X
Int J Cancer; 2018 Jun; 142(12):2543-2557. PubMed ID: 29368368
[TBL] [Abstract][Full Text] [Related]
2. Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR.
Du F; Qiao C; Li X; Chen Z; Liu H; Wu S; Hu S; Qiu Z; Qian M; Tian D; Wu K; Fan D; Nie Y; Xia L
Theranostics; 2019; 9(13):3879-3902. PubMed ID: 31281520
[No Abstract] [Full Text] [Related]
3. CircUBAP2 Inhibits Proliferation and Metastasis of Clear Cell Renal Cell Carcinoma via Targeting miR-148a-3p/FOXK2 Pathway.
Sun J; Yin A; Zhang W; Lv J; Liang Y; Li H; Li Y; Li X
Cell Transplant; 2020; 29():963689720925751. PubMed ID: 32425115
[TBL] [Abstract][Full Text] [Related]
4. Foxl1 inhibits tumor invasion and predicts outcome in human renal cancer.
Yang FQ; Yang FP; Li W; Liu M; Wang GC; Che JP; Huang JH; Zheng JH
Int J Clin Exp Pathol; 2014; 7(1):110-22. PubMed ID: 24427331
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of FOXO3a promotes tumor metastasis and is associated with metastasis-free survival of patients with clear cell renal cell carcinoma.
Ni D; Ma X; Li HZ; Gao Y; Li XT; Zhang Y; Ai Q; Zhang P; Song EL; Huang QB; Fan Y; Zhang X
Clin Cancer Res; 2014 Apr; 20(7):1779-90. PubMed ID: 24486593
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of miR-497 is associated with poor prognosis in renal cancer.
Zhao X; Zhao Z; Xu W; Hou J; Du X
Int J Clin Exp Pathol; 2015; 8(1):758-64. PubMed ID: 25755771
[TBL] [Abstract][Full Text] [Related]
7. CLEC3B is downregulated and inhibits proliferation in clear cell renal cell carcinoma.
Liu J; Liu Z; Liu Q; Li L; Fan X; Wen T; An G
Oncol Rep; 2018 Oct; 40(4):2023-2035. PubMed ID: 30066941
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of forkhead box M1 protein is associated with poor prognosis in clear cell renal cell carcinoma.
Wu XR; Chen YH; Liu DM; Sha JJ; Xuan HQ; Bo JJ; Huang YR
Med Oncol; 2013 Mar; 30(1):346. PubMed ID: 23263830
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of FOXK2 is associated with poor prognosis in patients with gastric cancer.
Liu X; Wei X; Niu W; Wang D; Wang B; Zhuang H
Mol Med Rep; 2018 Nov; 18(5):4356-4364. PubMed ID: 30221666
[TBL] [Abstract][Full Text] [Related]
10. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
Du P; Ye L; Yang Y; Jiang WG
Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253
[TBL] [Abstract][Full Text] [Related]
11. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR
Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
[TBL] [Abstract][Full Text] [Related]
12. EGFR protein overexpression correlates with chromosome 7 polysomy and poor prognostic parameters in clear cell renal cell carcinoma.
Dorđević G; Matušan Ilijaš K; Hadžisejdić I; Maričić A; Grahovac B; Jonjić N
J Biomed Sci; 2012 Apr; 19(1):40. PubMed ID: 22475688
[TBL] [Abstract][Full Text] [Related]
13. RhoB Acts as a Tumor Suppressor That Inhibits Malignancy of Clear Cell Renal Cell Carcinoma.
Chen W; Niu S; Ma X; Zhang P; Gao Y; Fan Y; Pang H; Gong H; Shen D; Gu L; Zhang Y; Zhang X
PLoS One; 2016; 11(7):e0157599. PubMed ID: 27384222
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.
Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH
Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of long non-coding RNA ENSG00000241684 is associated with poor prognosis in advanced clear cell renal cell carcinoma.
Su H; Wang H; Shi G; Zhang H; Sun F; Ye D
Eur J Surg Oncol; 2018 Jun; 44(6):840-846. PubMed ID: 29433989
[TBL] [Abstract][Full Text] [Related]
16. FOXD1 regulates cell division in clear cell renal cell carcinoma.
Bond KH; Fetting JL; Lary CW; Emery IF; Oxburgh L
BMC Cancer; 2021 Mar; 21(1):312. PubMed ID: 33761914
[TBL] [Abstract][Full Text] [Related]
17. miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.
Xu M; Gu M; Zhang K; Zhou J; Wang Z; Da J
Diagn Pathol; 2015 Apr; 10():24. PubMed ID: 25890121
[TBL] [Abstract][Full Text] [Related]
18. Tumor biology of non-metastatic stages of clear cell renal cell carcinoma; overexpression of stearoyl desaturase-1, EPO/EPO-R system and hypoxia-related proteins.
Stoyanoff TR; Rodríguez JP; Todaro JS; Espada JD; Colavita JP; Brandan NC; Torres AM; Aguirre MV
Tumour Biol; 2016 Oct; 37(10):13581-13593. PubMed ID: 27468719
[TBL] [Abstract][Full Text] [Related]
19. Effect of platelet-derived growth factor-B on renal cell carcinoma growth and progression.
Wang W; Qi L; Tan M; Zhang Z; Du J; Wei X; Yao X
Urol Oncol; 2015 Apr; 33(4):168.e17-27. PubMed ID: 25766258
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma.
Ma X; Shen D; Li H; Zhang Y; Lv X; Huang Q; Gao Y; Li X; Gu L; Xiu S; Bao X; Duan J; Zhang X
Urol Oncol; 2015 Apr; 33(4):169.e1-11. PubMed ID: 25700976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
